1. bookVolume 132 (2022): Edizione 1 (January 2022)
Dettagli della rivista
Prima pubblicazione
23 Apr 2014
Frequenza di pubblicazione
1 volta all'anno
Accesso libero

SARS-CoV-2 antibody screening in healthcare workers: lessons learned from the first months of COVID-19 outbreak in Europe. Significance of serology testing for effective pandemic management and reduction of the occupational risk

Pubblicato online: 20 Jul 2022
Volume & Edizione: Volume 132 (2022) - Edizione 1 (January 2022)
Pagine: 1 - 10
Dettagli della rivista
Prima pubblicazione
23 Apr 2014
Frequenza di pubblicazione
1 volta all'anno

1. Cheng S-C, Chang Y-C, Fan Chiang Y-L, et al. First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan. J Formos Med Assoc Taiwan Yi Zhi. 2020;119(3):747-51. Search in Google Scholar

2. Lai C-C, Shih T-P, Ko W-C, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924. Search in Google Scholar

3. WHO Director-General’s opening remarks at the media briefing on COVID-19 – 11 March 2020.. [https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-oncovid-19] (accessed: 1.06.2021) Search in Google Scholar

4. Download COVID-19 datasets. European Centre for Disease Prevention and Control. [https://www.ecdc.europa.eu/en/covid-19/data] (accessed: 1.06.2021) Search in Google Scholar

5. Rudberg A-S, Havervall S, Månberg A, et al. SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. Nat Commun. 2020;11(1):5064. Search in Google Scholar

6. He J, Guo Y, Mao R, Zhang J. Proportion of asymptomatic coronavirus disease 2019: A systematic review and meta-analysis. J Med Virol. 2021;93(2):820-30. Search in Google Scholar

7. Garcia-Basteiro AL, Moncunill G, Tortajada M, et al. Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital. Nat Commun. 2020;11(1):3500. Search in Google Scholar

8. European Centre for Disease Prevention and Control. [https://www.ecdc.europa.eu/en] (accessed: 1.06.2021) Search in Google Scholar

9. Parikh R, Mathai A, Parikh S, Chandra Sekhar G, Thomas R. Understanding and using sensitivity, specificity and predictive values. Indian J Ophthalmol. 2008;56(1):45-50. Search in Google Scholar

10. Guglielmi G. Fast coronavirus tests: what they can and can’t do. Nature. 2020;585(7826):496-8. Search in Google Scholar

11. Zhao J, Yuan Q, Wang H, et al. Antibody responses to SARS-CoV-2 in patients with Novel Coronavirus Disease 2019. Clin Infect Dis Off Publ Infect Dis Soc Am. 2020;71(16):2027-34. Search in Google Scholar

12. Bułdak RJ, Woźniak-Grygiel E, Wąsik M, et al. SARS-CoV-2 Antibody screening in healthcare workers in non-infectious hospitals in two different regions of Southern Poland (Upper Silesia and Opole Voivodeships): A Prospective cohort study. Int J Environ Res Public Health. 2021;18(8):4376. Search in Google Scholar

13. Yu H-Q, Sun B-Q, Fang Z-F, et al. Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients. Eur Respir J. 2020;56(2):2001526. Search in Google Scholar

14. Huang Z, Chen H, Xue M, et al. Characteristics and roles of severe acute respiratory syndrome coronavirus 2-specific antibodies in patients with different severities of coronavirus 19. Clin Exp Immunol. 2020;202(2):210-9. Search in Google Scholar

15. Guo L, Ren L, Yang S, et al. Profiling early humoral response to diagnose Novel Coronavirus Disease (COVID-19). Clin Infect Dis Off Publ Infect Dis Soc Am. 2020;71(15):778-85. Search in Google Scholar

16. Laboratory diagnostics SARS-CoV-2. [http://www.aotm.gov.pl/media/2021/04/Diagnostya-laboratoryjna-SARS-CoV-2-%E2%80%93-aktualizacja-Zalecen-wersja-2.0-7-kwietnia-2021-r.pdf] (accessed: 1.06.2021) Search in Google Scholar

17. Kavaliunas A, Ocaya P, Mumper J, et al. Swedish policy analysis for Covid-19. Health Policy Technol. 2020;9(4):598-612. Search in Google Scholar

18. Lidström A-K, Sund F, Albinsson B, et al. Work at inpatient care units is associated with an increased risk of SARS-CoV-2 infection; a cross-sectional study of 8679 healthcare workers in Sweden. Ups J Med Sci. 2020;125(4):305-10. Search in Google Scholar

19. Rashid-Abdi M, Krifors A, Sälléber A, et al. Low rate of COVID-19 sero-conversion in health-care workers at a Department of Infectious Diseases in Sweden during the later phase of the first wave; a prospective longitudinal seroepidemiological study. Infect Dis Lond Engl. 2021;53(3):169-75. Search in Google Scholar

20. He R, Zhang J, Mao Y, et al. Preparedness and responses faced during the COVID-19 pandemic in Belgium: An observational study and using the national open data. Int J Environ Res Public Health. 2020;17(21):7985. Search in Google Scholar

21. Silvia K. States of emergency in response to the coronavirus crisis: Situation in certain Member States; 2020. [https://www.europarl.europa.eu/RegData/etudes/STUD/2020/659385/EPRS_STU(2020)659385_EN.pdf] Search in Google Scholar

22. [https://www.gov.pl/web/belgia/informacja-w-zwiazku-z-rozprzestrzenianiem-sie-koronawirusa-w-belgii] (accessed 1.06.2021) Search in Google Scholar

23. Martin C, Montesinos I, Dauby N, et al. Dynamics of SARS-CoV-2 RTPCR positivity and seroprevalence among high-risk healthcare workers and hospital staff. J Hosp Infect. 2020;106(1):102-6. Search in Google Scholar

24. Spain against COVID-19. [http://pism.pl/publikacje/Hiszpania_wobec_pandemii_COVID19] (accessed 1.06.2021) Search in Google Scholar

25. Gras-Valentí P, Chico-Sánchez P, Algado-Sellés N, et al. Sero-epidemiological study of SARS-CoV-2 infection among healthcare personnel in a healthcare department. Enferm Infecc Microbiol Clin. 2021;39(7):319-25. Search in Google Scholar

26. Moncunill G, Mayor A, Santano R, et al. SARS-CoV-2 seroprevalence and antibody kinetics among health care workers in a Spanish Hospital after 3 months of follow-up. J Infect Dis. 2021;223(1):62-71. Search in Google Scholar

27. Plümper T, Neumayer E. Lockdown policies and the dynamics of the first wave of the Sars-CoV-2 pandemic in Europe. J Eur Public Policy. 2020;0(0):1-21. Search in Google Scholar

28. Shields A, Faustini SE, Perez-Toledo M, et al. SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study. Thorax. 2020;75(12):1089-94. Search in Google Scholar

29. Shields AM, Faustini SE, Perez-Toledo M, et al. Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response. MedRxiv Prepr Serv Health Sci. 2020. doi:10.1101/2020.11.12.20230763 Apri DOISearch in Google Scholar

30. Razvi S, Oliver R, Moore J, Beeby A. Exposure of hospital healthcare workers to the novel coronavirus (SARS-CoV-2). Clin Med Lond Engl. 2020;20(6):e238-e40. Search in Google Scholar

31. Martin CA, Patel P, Goss C, et al. Demographic and occupational determinants of anti-SARS-CoV-2 IgG seropositivity in hospital staff. J Public Health. 2020:1-12. Search in Google Scholar

32. Bampoe S, Lucas DN, Neall G, et al. A cross-sectional study of immune seroconversion to SARS-CoV-2 in frontline maternity health professionals. Anaesthesia. 2020;75(12):1614-9. Search in Google Scholar

33. Poulikakos D, Sinha S, Kalra PA. SARS-CoV-2 antibody screening in healthcare workers in a tertiary centre in North West England. J Clin Virol. 2020;129:104545. Search in Google Scholar

34. Di Lorenzo G, Di Trolio R. Coronavirus Disease (COVID-19) in Italy: Analysis of risk factors and proposed remedial measures. Front Med. 2020;7. doi:10.3389/fmed.2020.00140 Apri DOISearch in Google Scholar

35. Colombo AD, Impicciatore R. Analisi di 1.084 comuni italiani. In: Analisi dell’Istituto Cattaneo. Bologna: Fondazione di Ricerca istituto Carlo Cattaneo;2020. Search in Google Scholar

36. Conticini E, Frediani B, Caro D. Can atmospheric pollution be considered a co-factor in extremely high level of SARS-CoV-2 lethality in Northern Italy? Environ Pollut. 2020;261:114465. Search in Google Scholar

37. Murgante B, Borruso G, Balletto G, Castiglia P, Dettori M. Why Italy first? Health, geographical and planning aspects of the COVID-19 outbreak. Sustainability. 2020;12(12):5064. Search in Google Scholar

38. Lahner E, Dilaghi E, Prestigiacomo C, et al. Prevalence of Sars-Cov-2 infection in Health Workers (HWs) and diagnostic test performance: The experience of a Teaching Hospital in Central Italy. Int J Environ Res Public Health. 2020;17(12):4417. Search in Google Scholar

39. Plebani M, Padoan A, Fedeli U, et al. SARS-CoV-2 serosurvey in health care workers of the Veneto Region. Clin Chem Lab Med. 2020;58(12):2107-11. Search in Google Scholar

40. Calcagno A, Ghisetti V, Emanuele T, et al. Risk for SARS-CoV-2 Infection in Healthcare Workers, Turin, Italy. Emerg Infect Dis. 2021;27(1):303-5. Search in Google Scholar

41. Swiss Economy – Facts and Figures. [https://www.eda.admin.ch/about-switzerland/en/home/wirtschaft/uebersicht/wirtschaft---fakten-und-zahlen.html] (accessed: 1.06.2021) Search in Google Scholar

42. Giachino M, Valera CBG, Rodriguez Velásquez S, et al. Understanding the dynamics of the COVID-19 pandemic: A real-time analysis of Switzerland’s first wave. Int J Environ Res Public Health. 2020;17(23):8825. Search in Google Scholar

43. Kohler PP, Kahlert CR, Sumer J, et al. Prevalence of SARS-CoV-2 antibodies among Swiss hospital workers: Results of a prospective cohort study. Infect Control Hosp Epidemiol. 2021;42(5):604-8. Search in Google Scholar

44. France and COVID-19: Economic Priorities and the Risk of Recession. [http://pism.pl/publikacje/COVID19_we_Francji_priorytety_gospodarcze_wobec_widma_recesji] (accessed: 30.06.2021). Search in Google Scholar

45. COVID-19 in France - democracy in isolation.[http://pism.pl/publikacje/COVID19_we_Francji_demokracja_w_izolacji] (accessed: 30.06.2021). Search in Google Scholar

46. Delmas C, Plu-Bureau G, Canouï E, et al. Clinical characteristics and persistence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG antibodies in 4,607 French healthcare workers: Comparison with European countries. Infect Control Hosp Epidemiol. 2020:42(11):1406-8. Search in Google Scholar

47. Finkenzeller T, Faltlhauser A, Dietl K-H, et al. SARS-CoV-2 antibodies in ICU and clinic staff : From Germany’s region with the highest infection rate. Med Klin Intensivmed Notfallmedizin. 2020;115(Suppl 3):139-45. Search in Google Scholar

48. Péré H, Wack M, Védie B, et al. Sequential SARS-CoV-2 IgG assays as confirmatory strategy to confirm equivocal results: Hospital-wide antibody screening in 3,569 staff health care workers in Paris. J Clin Virol. 2020;132:104617. Search in Google Scholar

49. Mesnil M, Joubel K, Yavchitz A, et al. Seroprevalence of SARS-Cov-2 in 646 professionals at the Rothschild Foundation Hospital (ProSeCoV study). Anaesth Crit Care Pain Med. 2020;39(5):595-6. Search in Google Scholar

50. Naumann E, Möhring K, Reifenscheid M, et al. COVID-19 policies in Germany and their social, political, and psychological consequences. Eur Policy Anal. 2020;6(2):191-202. Search in Google Scholar

51. Korth J, Wilde B, Dolff S, et al. SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2020;128:104437. Search in Google Scholar

52. Schmidt SB, Grüter L, Boltzmann M, Rollnik JD. Prevalence of serum IgG antibodies against SARS-CoV-2 among clinic staff. PLoS ONE. 2020;15(6). doi:10.1371/journal.pone.0235417 Apri DOISearch in Google Scholar

53. Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2. Science Translational Medicine. [https://stm.sciencemag.org/content/12/573/eabe2555] (accessed: 1.06.2021) Search in Google Scholar

54. Amann J, Sleigh J, Vayena E. Digital contact-tracing during the Covid-19 pandemic: An analysis of newspaper coverage in Germany, Austria, and Switzerland. PLOS ONE. 2021;16(2):e0246524. Search in Google Scholar

55. Desson Z, Lambertz L, Peters JW, et al. Europe’s Covid-19 outliers: German, Austrian and Swiss policy responses during the early stages of the 2020 pandemic. Health Policy Technol. 2020;9(4):405-18. Search in Google Scholar

56. Pilz S, Chakeri A, Ioannidis JP, et al. SARS-CoV-2 re-infection risk in Austria. Eur J Clin Invest. 2021;51(4):e13520. Search in Google Scholar

57. Orth-Höller D, Eigentler A, Weseslindtner L, Möst J. Antibody kinetics in primary- and secondary-care physicians with mild to moderate SARSCoV-2 infection. Emerg Microbes Infect. 2020;9(1):1692-4. Search in Google Scholar

58. Hackner K, Errhalt P, Willheim M, et al. Diagnostic accuracy of two commercially available rapid assays for detection of IgG and IgM antibodies to SARS-CoV-2 compared to ELISA in a low-prevalence population. GMS Hyg Infect Control. 2020;15. doi:10.3205/dgkh000363 Apri DOISearch in Google Scholar

59. Conyon MJ, He L, Thomsen S. Lockdowns and COVID-19 deaths in Scandinavia. Social Sci Res Network. 2020. doi:10.2139/ssrn.3616969 Apri DOISearch in Google Scholar

60. Trieu M-C, Bansal A, Madsen A, et al. SARS-CoV-2 – Specific neutralizing antibody responses in Norwegian health care workers after the first wave of COVID-19 pandemic: A prospective cohort study. J Infect Dis. 2021;223(4):589-99. Search in Google Scholar

61. Basso T, Nordbø SA, Sundqvist E, et al. Transmission of infection from non-isolated patients with COVID-19 to healthcare workers. J Hosp Infect. 2020;106(4):639-42. Search in Google Scholar

62. Gujski M, Raciborski F, Jankowski M, et al. Epidemiological Analysis of the first 1389 cases of COVID-19 in Poland: A Preliminary report. Med Sci Monit Int Med J Exp Clin Res. 2020;26:e924702. Search in Google Scholar

63. Introducing an epidemic in Poland. Coronavirus: Information and Recommendations. [http://www.gov.pl/web/koronawirus/wprowadzamy-stan-epidemii-w-polsce] (accessed: 1.06.2021). Search in Google Scholar

64. The Impact of the COVID-19 Pandemic on Greek Policy. [https://pism.pl/publications/The_Impact_of_the_COVID19_Pandemic_on_Greek_Policy] (accessed: 1.06.2021). Search in Google Scholar

65. Moris D, Schizas D. Lockdown during COVID-19: The Greek success. In Vivo. 2020;34(3 suppl):1695-9. Search in Google Scholar

66. Vlachoyiannopoulos P, Alexopoulos H, Apostolidi I, et al. Anti-SARSCoV-2 antibody detection in healthcare workers of two tertiary hospitals in Athens, Greece. Clin Immunol Orlando Fla. 2020;221:108619. Search in Google Scholar

67. Galanis P, Kaitelidou D, Prezerakos P, et al. Low seropositivity for SARSCoV-2 antibodies among healthcare workers after the first COVID-19 pandemic wave in Greece. Public Health. 2021;198:223-9. Search in Google Scholar

68. Goverment website: When to get vaccinated before traveling?Ministry of Health. Web Gov.pl. [http://www.gov.pl/web/zdrowie/kiedy-nalezy-zaszczepic-sie-przed-podroza] (accessed 1.06.2021). Search in Google Scholar

Articoli consigliati da Trend MD

Pianifica la tua conferenza remota con Sciendo